Chemomab Therapeutics Ltd. (CMMB) 在获得顶级投资者3000万美元的私募融资前,其合并后公司的估值已高达1.5亿美元。这笔同步进行的私募配售进一步巩固了公司的资本实力,为后续发展提供了重要支持。
Chemomab Therapeutics Ltd. (CMMB) 在获得顶级投资者3000万美元的私募融资前,其合并后公司的估值已高达1.5亿美元。这笔同步进行的私募配售进一步巩固了公司的资本实力,为后续发展提供了重要支持。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.